idarubicin has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daniels, RL; Phelps, MC; Tavener, AM | 1 |
| Ames, MM; Kuffel, MJ; Reid, JM | 1 |
2 other study(ies) available for idarubicin and Glioma
| Article | Year |
|---|---|
Anthracycline-induced cytotoxicity in the GL261 glioma model system.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Comet Assay; Cytotoxins; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Glioma; Humans; Idarubicin; Mice; Models, Biological; Neuroglia | 2021 |
Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture.
Topics: Antibiotics, Antineoplastic; Cell Division; Daunorubicin; DNA Damage; DNA, Neoplasm; Doxorubicin; Epirubicin; Glioma; Humans; Idarubicin; Leukemia, Myeloid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1992 |